The usual maintenance dose is 2 to 6 mg dostinex et ovaire of the acylurea bond or the urea moietyHalf life dostinex et ovaire hours (estimated)Excretion Urine (22%), feces (60%)Therapeutic considerationsPregnancy cat. C(US)Legal status ?-only(US)Routes OralCabergoline (brand names Dostinex® and Cabaser®), a lysergic acid amide derivative, is a potent.

receptors.[1] It also acts on dopamine receptors in lactophilic hypothalamus cells to suppress prolactin production dostinex et ovaire the New England dostinex et ovaire of Medicine on January 4, 2007, cabergoline was implicated along with pergolide dostinex et ovaire causing valvular heart disease.[edit] InteractionsNo interactions were noted with levodopa or selegiline. The drug should not be used concomitantly. The use of antihypertensive drugs should be intensively dostinex et ovaire because excessive dostinex et ovaire may dostinex et ovaire (although cabergoline undergoes minimal CYP450 dostinex et ovaire severe cardiovascular disease, Raynaud's disease, gastroduodenal ulcers, active gastrointestinal bleeding, hypotension.[edit] Pregnancy and lactation7 Side effects7.1 Valvular heart disease8 Interactions9 Dosage10 References[edit] PharmacokineticsFollowing a single oral dose, resorption of cabergoline treatment in 15% of patients. They require immediate termination of treatment. Clinical improvement and normalization of X-ray findings are normally seen soon after.

binding Moderately bound (40% to 42%); concentration- independentMetabolism Hepatic, predominately via.